Feldschuh Jonathan Adam 4

What Happened
Jonathan Adam Feldschuh, DAXOR Corp.'s Chief Scientific Officer and a company director, was granted/received 25,000 shares on June 23, 2026. The reported acquisition price is $0.00, so the award had no cash purchase price; total reported value is $0. This is an award/vesting event (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: June 23, 2026; Form 4 filed: June 25, 2026 (timely within the 2-business-day rule).
• Transaction type/code: Award/Grant (A).
• Shares acquired: 25,000; price per share: $0.00; total reported consideration: $0.
• Footnote: F1 — the 25,000 shares granted vested on June 23, 2026.
• Shares owned after transaction: not specified in the details provided in your summary.
• No indication of a 10b5-1 plan, tax withholding, cashless sale, or other offset reported in the provided transaction info.

Context

• Awards that vest to executives are common forms of compensation and do not necessarily signal a bullish or bearish view by the insider.
• Because this was an award (not a purchase or sale), it reflects compensation/vesting rather than an insider buying additional exposure or cashing out.